Haemonetics market cap HAE

Share price times shares outstanding: what the whole company sells for, since 2010.

Haemonetics is worth $5.4B at the close on Oct 23, 2026, at $118.51 a share.

That is up 118% over the last year and up 54% over five years.

Its highest close in our data was $7.1B in Feb 2021.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$5.4B	$2.5B	$5.4B	+43%
2025	$3.8B	$2.3B	$4B	−4%
2024	$3.9B	$3.7B	$4.9B	−10%
2023	$4.3B	$3.7B	$4.7B	+9%
2022	$4B	$2.3B	$4.4B	+47%
2021	$2.7B	$2.6B	$7.1B	−55%
2020	$6B	$4B	$6.1B	+3%
2019	$5.9B	$4.2B	$7B	+19%
2018	$4.9B	$3.3B	$5.9B	+61%
2017	$3.1B	$2B	$3.1B	+48%
2016	$2.1B	$1.3B	$2.1B	+27%
2015	$1.6B	$1.6B	$2.3B	−17%
2014	$2B	$1.6B	$2.2B	−11%
2013	$2.2B	$2B	$2.3B	+8%
2012	$2.1B	$1.5B	$2.1B	+35%
2011	$1.5B	$1.4B	$1.8B	−2%
2010	$1.6B	$1.3B	$1.6B	n/a

Companies in Medical - Instruments & Supplies nearest Haemonetics' size, closest first, today.